Relyea Zuckerberg Hanson’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Buy
1,624
+175
+12% +$59.9K 0.05% 161
2026
Q1
$510K Buy
1,449
+74
+5% +$26.4K 0.05% 156
2025
Q4
$450K Buy
1,375
+97
+8% +$30.8K 0.05% 173
2025
Q3
$361K Sell
1,278
-341
-21% -$98.9K 0.04% 192
2025
Q2
$452K Sell
1,619
-100
-6% -$28.3K 0.05% 168
2025
Q1
$536K Buy
1,719
+105
+7% +$31K 0.07% 133
2024
Q4
$421K Sell
1,614
-6
-0.4% -$1.78K 0.06% 166
2024
Q3
$522K Buy
1,620
+77
+5% +$25.2K 0.08% 130
2024
Q2
$482K Sell
1,543
-101
-6% -$29.7K 0.08% 130
2024
Q1
$467K Buy
1,644
+299
+22% +$87.5K 0.08% 130
2023
Q4
$387K Buy
1,345
+399
+42% +$109K 0.08% 138
2023
Q3
$254K Buy
+946
New +$236K 0.06% 163
2023
Q2
Sell
-1,022
Closed -$247K 197
2023
Q1
$247K Buy
1,022
+181
+22% +$44.4K 0.06% 165
2022
Q4
$221K Buy
+841
New +$225K 0.06% 160

Other funds holding AMGN

Relyea Zuckerberg Hanson's AMGN Position: Q2 2026 in Review

Relyea Zuckerberg Hanson increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $59.9K and bringing the position to 1,624 shares worth $588K. The position accounts for 0.05% of the portfolio, ranked #161.

Relyea Zuckerberg Hanson first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Relyea Zuckerberg Hanson held 1,624 shares of Amgen worth $588K as of Q2 2026.
  • Relyea Zuckerberg Hanson bought 175 Amgen shares in Q2 2026, an estimated $59.9K.
  • Amgen made up 0.05% of Relyea Zuckerberg Hanson's portfolio in Q2 2026, its #161 holding.
  • Relyea Zuckerberg Hanson first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 1,435 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.